FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Cefixime

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot F201519, Expiry: November 2024
Where it was soldNationwide in the US
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Content Uniformity Specifications

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byLupin Limited, Mandideep, India foreign manufacturer
Brand nameCEFIXIME
Generic nameCEFIXIME
Active ingredient(s)CEFIXIME
Distributed by / forLupin Pharmaceuticals, Inc., Baltimore Maryland
NDC68180-407-03
Show the full FDA record
Full product labelCefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03
Recalling firmLupin Pharmaceuticals Inc.
DistributionNationwide in the US
Quantity3,552 bottles
Recall initiated2024-05-30
Report date2024-06-26
Recall completed2025-04-29
Recall numberD-0559-2024
ClassificationClass II
FDA statusTerminated
Origin on fileBaltimore MD United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.